ARTEC, Inc.

ARTEC, Inc. has made key appointments with the goal of initiating the production and global distribution of Tubercin and related immunostimulant medicines.

“R&D of Tubercin is complete, requiring no further refinement or alteration in terms of its formulation. Our new business associates are joining ARTEC, Inc. in order to stimulate and enforce the production of this potentially promising immunostimulant to combat HIV and Cancer,” said Dr. Ronald Shinn, president and chairman of the board of directors of ARTEC. “Our board members will utilize their experience in the areas of product enterprise, contract negotiations and strategic investments to insure that the production and distribution of Tubercin will develop in a way that is internationally accessible while remaining affordable.”

George E. Williams, Jr., has been appointed as director. He previously served as vice president of Hana Security Services, a company that provides civilian personnel for the U.S. Department of Defense throughout the U.S. Mr. Williams is also an experienced negotiator in working with governmental contracts throughout the world.

Rodney Watson has been appointed coordinator for ARTEC, South Africa. Mr. Watson was previously business manager for Innovative Investment Holding PPY in Johannesburg, Republic of South Africa. He is a successful business leader in South Africa along with other areas of Africa, responsible for overseeing large acquisitions and activating the funding of state-of-the-art technology projects.

Cecil Thompson will serve as coordinator for ARTEC, Bahamas. He is currently president of Certified Consultants, Inc. Mr. Thompson brings an expertise in property development funding, mining and new business ventures.

Gerry Knight, executive vice president of the company has been appointed as coordinator for the funding of special projects and will focus on the development of the South Africa and Bahamas operations.